
NATURAL ALTERNATIVES INTERNATIONAL INC
94
Recent quarterly results show widening losses year-over-year amid margin pressures, alongside some sales growth. The company has extended key manufacturing partnerships and maintains active risk management practices.
- Natural Alternatives reported a widening net loss in Q4 2026 compared to the prior year, attributed to margin pressures [N1].
- Q3 2026 results also showed increased losses year-over-year with margin challenges [N3].
- Q2 2026 saw a widening loss year-over-year despite sales increases [N4].
- The company extended a multi-year manufacturing agreement with The Juice Plus+ Company in mid-2025 [N8].
- Zacks initiated coverage of NAII with a neutral recommendation in late 2025 [N6].
- The company maintains an enterprise risk management program including cybersecurity risk oversight by senior management and the Board of Directors [S1].
- Liquidity as of September 30, 2026, included $6.485 million in cash and equivalents, with a current ratio of 1.37 [S2].
Natural Alternatives International Inc is a company engaged in the healthcare and nutritional supplements industry, focusing on manufacturing and partnerships with other firms such as The Juice Plus+ Company. The company has experienced increasing sales in some periods but has also reported widening net losses and margin pressures in recent quarters. It maintains a comprehensive enterprise risk management program, including cybersecurity risk oversight by senior management and the Board of Directors. Financial data from SEC filings as of September 2026 shows moderate liquidity with a current ratio above 1.3 and a cash position of approximately $6.5 million. The company publishes clinical trial results related to its products and has ongoing partnerships supporting its manufacturing operations.
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Natural Alternatives International Inc has reported widening net losses in recent quarters amid margin pressures, despite some sales growth. The company maintains active risk management including cybersecurity oversight. Recent news and SEC filings provide detailed visibility into its financial condition and business developments.
The company has demonstrated the ability to increase sales in certain periods and maintain strategic partnerships that support its manufacturing business. Its focus on clinical research and product innovation may enhance its market position. The enterprise risk management framework and cybersecurity oversight indicate a structured approach to managing operational risks.
Despite sales growth, the company has reported widening net losses and margin pressures in recent quarters, which may reflect challenges in cost control or competitive pressures. The relatively low cash ratio and ongoing net losses highlight liquidity and profitability risks. Cybersecurity threats remain a potential material risk despite current controls. The company's financial performance and risk factors could negatively impact its business and stock value.
Natural Alternatives International Inc's moat appears to be based on its specialized manufacturing capabilities in the nutritional supplements sector and established multi-year partnerships with companies like The Juice Plus+ Company. Its clinical trial publications and product development efforts contribute to its competitive positioning. However, the company faces margin pressures and net losses, indicating challenges in profitability and cost management.
• Financial Performance Risk: The company has reported widening net losses and margin pressures in recent quarters, which could impact its financial stability and operational flexibility.
• Liquidity Risk: With a cash ratio of 0.16 as of September 2026, liquidity may be constrained, potentially affecting the company's ability to meet short-term obligations.
• Cybersecurity Risk: Although no material breaches have occurred, ongoing cybersecurity threats pose a risk that could materially affect the company's business and financial condition.
• Market and Competitive Risk: The nutritional supplements industry is competitive and subject to regulatory changes, which could affect the company's sales and profitability.
Business trends: Sales growth in some periods contrasts with widening net losses and margin pressures, reflecting operational challenges and competitive pressures.
Execution milestones: Extension of multi-year manufacturing partnerships and maintenance of enterprise risk management including cybersecurity oversight.
Key risks: Financial losses impacting liquidity and profitability, cybersecurity threats, and competitive/regulatory challenges in the nutritional supplements industry.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Natural Alternatives International Inc operates in the healthcare/nutritional supplements sector with a focus on manufacturing and partnerships in this space.
- The company has reported widening net losses year-over-year in recent quarters, with margin pressures noted in Q2, Q3, and Q4 of fiscal 2026.
- Sales have shown increases in some periods, including a 15% year-over-year sales rise in Q4 fiscal 2025.
- The company extended a multi-year manufacturing partnership with The Juice Plus+ Company, indicating ongoing business relationships.
- Financial snapshot as of September 30, 2026, shows cash and equivalents of $6.485 million, current assets of $54.3 million, current liabilities of $39.6 million, resulting in a current ratio of 1.37 and a cash ratio of 0.16.
- Net income was negative $2.381 million as of September 25, 2026, with basic and diluted EPS of -$0.41 per share.
- The company maintains an enterprise risk management function including cybersecurity risk management overseen by senior management and the Board of Directors.
- No material cybersecurity breaches have been reported, but the company acknowledges ongoing cybersecurity risks and the potential for material impact if an attack occurs.
- The Audit Committee of the Board oversees risk management including cybersecurity risks, with senior management responsible for day-to-day risk management.
- Recent news highlights include quarterly financial results showing increased sales but continued net losses and margin pressures, as well as coverage initiation with a neutral recommendation by Zacks.
- The company has a history of clinical trial publications related to its products, such as TriBsyn™ Beta-Alanine supplementation.
- Liquidity ratios and financial figures are summarized from the latest SEC filings and provided for informational purposes only.
Generated 2026-11-14
- S1 | 2026-09-28 | 10-K
- S2 | 2026-11-13 | 10-Q
- N1 | 2026-09-29 | www.nasdaq.com | Natural Alternatives Q4 Loss Widens Y/Y on Margin Pressure | https://www.nasdaq.com/articles/natural-alternatives-q4-loss-widens-y-y-margin-pressure
- N2 | 2026-08-06 | www.nasdaq.com | 3 Microcaps for Your Watchlist | https://www.nasdaq.com/articles/3-microcaps-your-watchlist
- N3 | 2026-06-01 | www.nasdaq.com | Natural Alternatives Q3 Loss Widens Y/Y on Margin Pressure | https://www.nasdaq.com/articles/natural-alternatives-q3-loss-widens-y-y-margin-pressure
- N4 | 2026-02-18 | www.nasdaq.com | Natural Alternatives Q2 Loss Widens Y/Y, Sales Increase | https://www.nasdaq.com/articles/natural-alternatives-q2-loss-widens-y-y-sales-increase
- N5 | 2026-01-15 | www.nasdaq.com | Niche Focus & Regulation Shape the Future of Healthcare Firms | https://www.nasdaq.com/articles/niche-focus-regulation-shape-future-healthcare-firms
- N6 | 2025-10-27 | www.nasdaq.com | Zacks Initiates Coverage of NAII With Neutral Recommendation | https://www.nasdaq.com/articles/zacks-initiates-coverage-naii-neutral-recommendation
- N7 | 2025-10-02 | www.nasdaq.com | Natural Alternatives Q4 Sales Rise 15% Y/Y, Loss Widens for FY25 | https://www.nasdaq.com/articles/natural-alternatives-q4-sales-rise-15-y-y-loss-widens-fy25
- N8 | 2025-07-21 | www.nasdaq.com | Natural Alternatives International Extends Partnership with The Juice Plus+ Company in Multi-Year Manufacturing Agreement | https://www.nasdaq.com/articles/natural-alternatives-international-extends-partnership-juice-plus-company-multi-year
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


